Learn about the potential side effects of iron protein succinylate. Includes common and rare side effects information for consumers and healthcare professionals. Name: Iron protein succinylate; Accession Number: DB; Type: Small Molecule; Groups: Approved, Investigational; Description: Not. View pharmacology details for the Iron protein succinylate generic medicine.
|Published (Last):||23 March 2006|
|PDF File Size:||18.25 Mb|
|ePub File Size:||13.50 Mb|
|Price:||Free* [*Free Regsitration Required]|
iron protein succinylate Publications | PubFacts
However, we do publish a comprehensive directory of Pharmacies, Chemists and Druggists in cities all over India. A product containing a high amount of iron and maintaining all the necessary characteristics of stability and solubility for a drug can be prepared by succinylating the proteins, in the specific case the milk proteins, before the reaction with the iron salt.
These observations confirm that, although the most modern preparations of ferrous sulphate exhibit a relatively low frequency of adverse events of limited clinical concern, it is nevertheless possible to decrease both the prevalence and the duration of such events without prejudice for the clinical efficacy, with the use of more “physiological” preparations in which the iron is reversibly bound to a protein carrier, thus effectively removing one of the main obstacles to the correct compliance with treatments that must be administered for prolonged periods of time.
Acta Haematol 31; 1: Epub Dec A prospective, controlled, double-blind, double-dummy, multicenter clinical trial was made to assess the efficacy and tolerability of iron-protein-succinylate ITF in comparison with a well known iron preparation in the treatment of iron deficiency or iron deficient anemia. A comparative study on the gastroduodenal tolerance of different antianaemic preparations.
Boll Chim Farm Mar; 3: Comparison of anti-anaemic effects of iron protein succinylate ITF and ferrous sulfate in the rat. The most significant adverse effect of repeated oral administration of iron-containing antianaemic preparations is the succinylaate toxicity, attributable to a direct toxic effect of iron on the glandular epithelium.
Some or all pharmacies who provide a home delivery service for medicines might insist on a prescription for iron protein succinylate before they complete the sale. One hundred and thirty anemic pregnant women were studied.
Serum ironn concentration significantly increased compared with baseline values only in patients given iron protein succinylate. Iron protein succinylate in the treatment irn iron deficiency: Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children.
In 6 fasting, conscious dogs, fitted with 8 bipolar electrodes and 3 strain-gauge force transducers along the gastrointestinal tract, gastrointestinal motor activity was recorded. Treatment began at two weeks after wuccinylate.
For these derivatives a particular advantage can be achieved, the iron succinyl protein precipitates at the pH of the iroj further keeping the iron bonded and it re-solubilizes at pH higher than 7, the intestine pH level.
Iron complex, dabigatran and toxic epidermal necrolysis syndrome: Absorption of iron from iron succinyl-protein complexes by mouse small intestine.
Iron protein succinylate Pharmacology
J Pharm Biomed Anal Aug;29 6: Inclusion criteria were iron-deficiency type of anemia, and hemoglobin levels below of Hum Exp Toxicol Mar;22 3: A prospective, open, multicenter clinical trial was set up to evaluate the potential interaction of ITF with H2-receptor antagonists in patients affected with iron deficiency. Arzneimittelforschung Nov;45 Physical Medicine and Rehabilitation Arzneimittelforschung ;34 9: This paper provides an overview of the pharmacokinetic and clinical data on Fe-ASP succinnylate.
Studying the gastrointestinal motor effects of iron compounds may help to elucidate the mechanism originating the gastrointestinal side effects of frequently reported during martial therapy. Drugs Exp Clin Res ;16 7: Minerva Ginecol May;42 5: Chiara Hospital, Pisa, Italy.
Iron absorption and kinetics were evaluated by measuring serum iron after oral administration of equidoses of iron to the anaemic rat. Treatment of iron deficiency conditions in blood donors: Clin Ther ;10 4: The first aim of succinypate meta-analysis is to verify the increase of hemoglobin Hb in these patients treated with ITF, treated with iron sulphate and treated with iron-polysterene sulphonate.
To evaluate whether folate supplementation to iron is able to accelerate solving of iron deficiency anaemia in pregnancy.